The candidate TB vaccine, MVA85A, induces highly durable Th1 responses. by Tameris, M, Geldenhuys, H, Luabeya, A, Smit, E, Hughes, J, Vermaak, S, Hanekom, W, Hatherill, M, Mahomed, H, Mcshane, H, Scriba, T

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses by Tameris, M, Geldenhuys, H, Luabeya, A, Smit, E, Hughes, J, Vermaak, S, Hanekom, W, Hatherill, M, Mahomed, H, McShane, H, Scriba, T

Comparison of haematology and biochemistry parameters in healthy South African infants with laboratory reference intervals. by Schmidt, B, Tameris, M, Geldenhuys, H, Luabeya, A, Bunyasi, E, Hawkridge, T, McClain, J, Mahomed, H, Scriba, T, McShane, H, Hatherill, M

Elevated IgG responses in infants are associated with reduced prevalence of Mycobacterium tuberculosis infection by Logan, E, Luabeya, A, Mulenga, H, Mrdjen, D, Ontong, C, Cunningham, A, Tameris, M, McShane, H, Scriba, T, Horsnell, W, Hatherill, M

Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination by Bunyasi, E, Luabeya, A, Tameris, M, Geldenhuys, H, Mulenga, H, Landry, B, Scriba, T, Schmidt, B, Hanekom, W, Mahomed, H, McShane, H, Hatherill, M

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG. by Tameris, M, McShane, H, McClain, J, Landry, B, Lockhart, S, Luabeya, A, Geldenhuys, H, Shea, J, Hussey, G, van der Merwe, L, de Kock, M, Scriba, T, Walker, R, Hanekom, W, Hatherill, M, Mahomed, H

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG by Tameris, M, McShane, H, McClain, J, Landry, B, Lockhart, S, Luabeya, A, Geldenhuys, H, Shea, J, Hussey, G, Van Der Merwe, L, De Kock, M, Scriba, T, Walker, R, Hanekom, W, Hatherill, M, Mahomed, H